Saltar al contenido principal

Lamentablemente no somos totalmente compatibles con su navegador. Si tiene la opción, actualice a una versión más reciente o utilice Mozilla Firefox, Microsoft Edge, Google Chrome o Safari 14 o posterior. Si no puede y necesita ayuda, envíenos sus comentarios.

Agradeceríamos sus comentarios sobre esta nueva experiencia.Díganos qué piensa se abre en una nueva pestaña/ventana

Elsevier
Publique con nosotros
Press release

Elsevier Unveils Rigorous Evaluation Framework to Mitigate Risk in Generative AI Clinical Decision Support Tools 

4 de junio de 2025

Clinician-centered framework will be featured in upcoming issue of the Open Access Journal of the American Medical Informatics Association (JAMIA)

Initial evaluations of ClinicalKey AI show high accuracy and usefulness in responses amongst clinicians

Elsevier, a global leader in medical information and data analytics, unveiled a groundbreaking evaluation framework for assessing the performance and safety of generative AI-powered clinical reference tools. This innovative approach has been developed for all Elsevier Health generative AI solutions, including ClinicalKey AI, Elsevier's advanced clinical decision support platform, and sets a new standard for responsible AI integration in healthcare. It will be featured in a future issue of the Open Access Journal of the American Medical Informatics Association (JAMIA).  

The framework, designed with input from clinical subject matter experts across multiple specialties, evaluates AI-generated responses along five critical dimensions: query comprehension, response helpfulness, correctness, completeness, and potential for clinical harm. It serves as a comprehensive assessment to ensure that AI-powered tools not only provide accurate and relevant information but also align with the practical and current needs of healthcare professionals at the point of care. 

Omry Bigger, President of Clinical Solutions at Elsevier: “This evaluation framework not only supports innovation and advancements to improve patient care but adds an extra layer of review and assessment to ensure physicians are armed with the most accurate information possible. It’s a critical step in the implementation of responsible AI for healthcare providers and patients.”  

In a recent evaluation study of ClinicalKey AI, Elsevier worked with a panel of 41-board certified physicians and clinical pharmacists to rigorously test responses generated by the tool for a diverse set of clinical queries. That panel evaluated 426 query-response pairs, and results demonstrated impressive performance, with 94.4% of responses rated as helpful, 95.5% assessed as completely correct, with just 0.47% flagged for potential improvements. 

Leah Livingston, Director of Generative AI Evaluation for Health Markets at Elsevier, said: “These results reflect not just strong performance, but the real value of bringing clinicians into the evaluation process. By designing an evaluation framework around what matters most to physicians—accuracy, relevance, and clinical safety —we’re helping ensure that AI tools truly add value to care delivery. This approach supports clinicians in quickly accessing the right information, ultimately reducing cognitive burden.” 

Elsevier is continuing to implement AI responsibly in its portfolio of AI solutions and is also involved in industry-wide initiatives. As a proud partner of the Coalition for Health AI, the company is actively contributing to industry-wide standards for responsible AI deployment in healthcare settings. 

The release of the evaluation framework represents a significant step forward in the responsible integration of AI technologies in healthcare, paving the way for more efficient, accurate, and patient-centered clinical decision-making.  

To learn more details about the evaluation framework, a white paper is available for download: Evaluation framework for generative AI tools used for clinical decision support

Acerca de Elsevier

Como líder mundial en información y análisis científicos, Elsevier ayuda a los investigadores y profesionales de la salud a hacer avanzar la ciencia y mejorar los resultados de salud en beneficio de la sociedad. Lo hacemos facilitando conocimientos y la toma de decisiones críticas con soluciones innovadoras basadas en contenido confiable y basado en evidencia y tecnologías digitales avanzadas habilitadas por IA. Hemos apoyado el trabajo de nuestras comunidades de investigación y atención médica durante más de 140 años. Nuestros 9500 empleados en todo el mundo, incluidos 2300 tecnólogos, se dedican a apoyar a investigadores, bibliotecarios, líderes académicos, financiadores, gobiernos, empresas intensivas en I+D, médicos, enfermeras, futuros profesionales de la salud y educadores en su trabajo crítico. Nuestras 2900 revistas científicas y libros de referencia icónicos incluyen los títulos más importantes en sus campos, incluidos Cell Press, The Lancet y Gray's Anatomy. Junto con Elsevier Foundation se abre en una nueva pestaña/ventana, trabajamos en asociación con las comunidades a las que servimos para promover la inclusión y la diversidad en la ciencia, la investigación y la atención médica en los países en desarrollo y en todo el mundo. Elsevier es parte de RELX, un proveedor global de herramientas de toma de decisiones y análisis basados ​​en información para clientes profesionales y comerciales. Para obtener más información sobre nuestro trabajo, soluciones digitales y contenido, visite www.elsevier.com.

Contacto

Chris West

CW

Chris West

Senior Communications Manager, Health Markets

Elsevier

+1 703 967 3990

Correo electrónico Chris West